| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $342.3M | +2.8% |
| Cost of Revenue | $72.8M | -6.2% |
| Gross Profit | $269.6M | +5.6% |
| R&D Expense | $73.0M | -9.7% |
| SG&A Expense | $55.9M | -9.6% |
| Operating Income | -$16.2M | +61.1% |
| Interest Expense | $10.0M | +65.7% |
| Pre-tax Income | -$18.2M | +30.1% |
| Income Tax | $1.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.3M | -50.2% |
| Short-term Investments | $96.8M | +8.5% |
| Accounts Receivable | $50.0M | +3.8% |
| Current Assets | $214.4M | -14.7% |
| Total Assets | $308.8M | -9.3% |
| Current Liabilities | $108.2M | +22.9% |
| Long-term Debt | $157.0M | -27.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.5M | -2.9% |
| Investing Cash Flow | -$16.6M | -115.8% |
| Financing Cash Flow | -$53.1M | +53.5% |
| +14.9% |
| Net Income | -$19.3M | +28.4% |
| EPS (Basic) | -$0.24 | +31.4% |
| EPS (Diluted) | -$0.24 | +31.4% |
| Total Liabilities |
| $269.4M |
| -12.2% |
| Stockholders' Equity | $39.4M | +17.9% |